The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / How to Maintain Connections with Colleagues, Staff & Patients During a Pandemic: A Q&A with Reshma Khan, MD

How to Maintain Connections with Colleagues, Staff & Patients During a Pandemic: A Q&A with Reshma Khan, MD

April 17, 2020 • By Linda Childers

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Reshma Khan, MD

As the cases of COVID-19 continue to rise in South Florida, Reshma Khan, MD, a rheumatologist at the Palm Beach Rheumatology and Wellness Center, Jupiter, Fla., is being careful to emphasize social distancing, but not social isolation. Dr. Khan believes that, during this pandemic, it’s more important than ever for rheumatologists to share support and best practices.

You Might Also Like
  • New Processes May Stick Around After the Pandemic: Q&A with Wendy Ramey, BSPharm, RPh, CSP
  • Adapting Care for Pediatric Patients & Parents During the Pandemic: Q&A with Sangeeta Sule, MD, PhD
  • Finding Opportunity Through Challenge: Q&A with Vaneet K. Sandhu, MD, FACR, RhMSUS
Also By This Author
  • The 2020 ARP Merit Awards & ACR Distinguished Fellows

The Rheumatologist recently spoke with Dr. Khan to learn how she’s maintaining connections during the pandemic.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Q: How are you and your staff adapting to the sudden changes brought about by the pandemic?
I started a Facebook group called Women Rheumatologists Group (WRG) four years ago, and this past March, the topic of COVID-19 began coming up. Physicians were talking about ways we could prepare for cases, and my staff and I developed a plan to triage and treat patients in the event of an outbreak.

In early March, we began screening patients over the phone. If they had recently traveled outside of the country or taken a cruise, we booked their appointments two to three weeks out, so there wouldn’t be at risk of spreading the disease. I also set up my computers and cameras to do telemedicine, if needed. I’m glad we had precautionary procedures in place because several rheumatologist friends had to close their offices for several weeks due to COVID-19 exposure.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Q: What types of appointments are you conducting?
In March, before the government announced the pandemic, we started conducting 50% of our appointments through telemedicine. The biggest concern was whether insurance companies would appropriately compensate for our time through telemedicine. However, I did what I thought was best for my patients, and now, we see almost everyone virtually. Infusion and injection patients are still making office visits, but their appointments are spread out, and we only see one patient at a time.

Q: What are you telling patients about COVID-19’s potential risks and symptoms? What are their chief concerns?
When I speak to patients, I stress the importance of social distancing and explain [that] if they are on biologics, they may be more susceptible to COVID-19 infection. I also discuss coronavirus symptoms and how prevention is best, [because] there is currently no cure.

One of the biggest concerns is whether they can continue to receive their medications. Hydroxychloroquine, used to treat lupus and rheumatoid arthritis, is in short supply [because] it’s being studied as a potential therapy for COVID-19. Patients who typically receive a 90-day supply can now only receive a 14-day supply from many pharmacies. For some patients, we also received forms from their pharmacy to do prior authorization. It was more work on our end, but at least we’re able to secure a 30-day supply for patients.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: Professional Topics Tagged With: coronavirus, COVID-19, Practice Management, rheumatologists, telemedicine

You Might Also Like:
  • New Processes May Stick Around After the Pandemic: Q&A with Wendy Ramey, BSPharm, RPh, CSP
  • Adapting Care for Pediatric Patients & Parents During the Pandemic: Q&A with Sangeeta Sule, MD, PhD
  • Finding Opportunity Through Challenge: Q&A with Vaneet K. Sandhu, MD, FACR, RhMSUS
  • The Personal Side of COVID-19: Q&A with Philip A. Waller, MD

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)